Modulated Imaging, Inc.


Modulim is a medical device company that develops and commercializes non-contact optical imaging and data platforms for quantitative assessment of tissue microvascular health. The company’s technology measures tissue oxygenation and hemoglobin distribution at the point of care, integrates imaging with a HIPAA-compliant cloud for data management and analytics, and has published clinical validation studies and regulatory clearances.

Industries

N/A

Nr. of Employees

small (1-50)

Modulated Imaging, Inc.


Products

Non-contact optical imaging system for microvascular assessment

A point-of-care, non-contact imaging system that uses structured-light multispectral imaging to quantify tissue oxygenation and hemoglobin distribution and produce 2D biomarker maps; reported as cleared by relevant regulatory bodies.


Services

A programmatic solution that combines point-of-care microvascular imaging with cloud-based data sharing and multidisciplinary care coordination to manage high-risk patients.

HIPAA-compliant cloud for secure storage, indexing, curated patient timelines, and population-level dashboards to support clinical decision-making.

Software tools to present tailored worklists, enable remote disposition, and share imaging data for collaboration and second opinions.

Expertise Areas

  • Microvascular optical imaging
  • Point-of-care diagnostics for tissue perfusion
  • Clinical validation and biomarker research
  • Medical device development and regulatory compliance
  • Show More (3)

Key Technologies

  • Spatial frequency domain imaging (SFDI)
  • Structured-light multispectral imaging (visible and near-infrared)
  • Layer-specific hemoglobin and oxygenation mapping
  • Cloud-based HIPAA-compliant analytics
  • Show More (2)

News & Updates

Three-year renewal of ISO 13485 certification following a review of the company's quality system covering design, manufacturing, and customer management.

Two-year contract (~$2.5M) to develop a handheld digital burn assessment tool leveraging multispectral structured-light imaging.

Publication reporting that SFDI biomarkers correlate with clinical severity and can stratify microvascular disease in the foot.

Case report publication demonstrating SFDI use to evaluate microvascular oxygenation and perfusion before and after revascularization procedures.

Issued United States patent covering systems and methods for assessing diabetic circulatory complications using structured-light multispectral imaging and model-based chromophore mapping.

Obtained CE Mark allowing distribution and marketing in jurisdictions recognizing the CE certification.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.